Publications by authors named "Helena Gama"

Claim this Profile
D
Drug-Drug Interaction between Oral Zamicastat and Continuous Epoprostenol Infusion at Steady-State Conditions in Healthy Subjects.
Marlene Fonseca, Andreia Guimarães, Helena Gama, Luís Magalhães, Sara Carolina Henriques

J Clin Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of zamicastat on blood pressure and heart rate response to cold pressor test: A double-blind, randomized, placebo-controlled study in healthy subjects.
Marlene Fonseca, Cheila Ribeiro, Guillermo Castilla-Fernández, Helena Gama, Luís Magalhães

Br J Clin Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of adjunctive eslicarbazepine acetate in adult Asian patients with refractory focal seizures: Post hoc analysis of a phase III trial.
Sang Kun Lee, Sang Ahm Lee, Seung Bong Hong, Yong Won Cho, Guillermo Castilla-Fernández, Helena Gama

Clin Transl Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirteen years of experience with eslicarbazepine acetate in the United Kingdom and Republic of Ireland: A safety perspective.
Luís Guedes, Mariana Vieira, Helena Gama, Daniel Magano, Maria Fernandes

Epileptic Disord· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term quality of life in patients with focal seizures treated with adjunctive eslicarbazepine acetate.
Suparna R Krishnaiengar, David Cantu, Diane Hall, Helena Gama, Ana Pereira

Epilepsy Behav· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A analysis of BIPARK-I and II.
José-Francisco Rocha, Georg Ebersbach, Andrew Lees, Eduardo Tolosa, Joaquim J Ferreira, Helena Gama

Front Neurol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers.
José-Francisco Rocha, Ana Santos, Helena Gama, Paul Moser, Amílcar Falcão

Clin Pharmacol Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term therapeutic effect of eslicarbazepine acetate in children: An open-label extension of a cognition study in children aged 6-16 years.
Pierangelo Veggiotti, Sergiusz Józwiak, Fenella Kirkham, Joana Moreira, Ana Pereira, Helena Gama

Epilepsy Behav· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Analysis of BIPARK-I and -II.
José-Francisco Rocha, Georg Ebersbach, Andrew Lees, Eduardo Tolosa, Joaquim J Ferreira, Helena Gama

Front Neurol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience.
Luís M Magalhães, Raquel Costa, Mariana Vieira, Joana Moreira, Helena Gama

Drug Saf· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (≥60 years) and younger (18-59 years) adults.
Eva Andermann, William Rosenfeld, Patricia Penovich, Joanne Rogin, Fernando Cendes, Helena Gama

Epilepsy Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and tolerability of adjunctive eslicarbazepine acetate in children with focal seizures.
Raman Sankar, Fenella J Kirkham, Gregory L Holmes, J Eric Pina-Garza, James Wheless, Helena Gama

Epilepsy Behav· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Profile of Opicapone in the Management of Parkinson's Disease.
Andrew Lees, Joaquim J Ferreira, José-Francisco Rocha, Olivier Rascol, Werner Poewe, Helena Gama

J Parkinsons Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate.
Joanne Rogin, Trevor Resnick, Laura Strom, Elinor Ben-Menachem, Silvia Kochen, Helena Gama

Acta Neurol Scand· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial.
Fenella Kirkham, Stéphane Auvin, Joana Moreira, Helena Gama, Amílcar C Falcão

Epilepsy Behav· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged ≥ 65 Years with Focal Seizures.
Raquel Costa, Bernhard Steinhoff, Helena Gama, Fábio Ikedo, José-Francisco Rocha

Drugs Aging· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures.
Bassel Abou-Khalil, Pavel Klein, Aashit Shah, Philippe Ryvlin, Luigi M Specchio, Helena Gama

Epilepsy Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.
Eva Andermann, Victor Biton, Selim R Benbadis, Bassel Shneker, Aashit K Shah, Helena Gama

Epilepsy Behav· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eslicarbazepine acetate exposure in pregnant women with epilepsy.
Raquel Costa, Luís M Magalhães, Joana Graça, Mariana Vieira, Helena Gama

Seizure· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials.
Gregory Krauss, Victor Biton, Jay H Harvey, Christian Elger, Eugen Trinka, Helena Gama

Epilepsy Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Profile of Eslicarbazepine Acetate as Add-On Therapy in Adults with Refractory Focal-Onset Seizures: From Clinical Studies to 6 Years of Post-Marketing Experience.
Helena Gama, Mariana Vieira, Raquel Costa, Joana Graça, Luís M Magalhães

Drug Saf· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies.
Christian Elger, Mathias Koepp, Eugen Trinka, Vicente Villanueva, João Chaves, Helena Gama

CNS Neurosci Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Victor Biton, Joanne B Rogin, Gregory Krauss, Bassel Abou-Khalil, José F Rocha, Helena Gama

Epilepsy Behav· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal.
Helena Gama, Carla Torre, José Pedro Guerreiro, Ana Azevedo, Suzete Costa

BMC Health Serv Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of medicines by homeless people in Porto, Portugal.
Helena Gama, Luís Oliveira, Maria de Lurdes Pereira, Ana Azevedo, Nuno Lunet

Cad Saude Publica· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis